Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
| ▸ | METAP1 | P53582 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | BTK | Q06187 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4044137 | 0.84 | PDE9A (0.38) | METAP2METAP1 | |
| SCHEMBL4042151 | 0.82 | AAK1 (0.40) | METAP2METAP1MAPTPDE3BPDE3A | |
| SCHEMBL4052403 | 0.82 | METAP2 (0.36) | METAP2METAP1EGLN1 | |
| SCHEMBL4047107 | 0.82 | PDE9A (0.35) | ADORA3ADORA2AADORA2BADORA1METAP2 | |
| SCHEMBL13905292 | 0.82 | PDE9A (0.35) | ADORA3ADORA2AADORA2BADORA1METAP2 | |
| SCHEMBL4053122 | 0.80 | GPR84 (0.47) | METAP2METAP1PDE3BPDE3A | |
| SCHEMBL4046994 | 0.79 | ADORA1 (0.42) | ADORA3ADORA2AADORA1GSK3BMETAP2 | |
| SCHEMBL4046849 | 0.77 | METAP2 (0.35) | METAP2METAP1 | |
| SCHEMBL4052252 | 0.76 | KDM4C (0.41) | ADORA3ADORA2AADORA1GSK3BMETAP2 | |
| SCHEMBL4047518 | 0.75 | METAP2 (0.33) | METAP2METAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009029592-A1 | HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | KALYPSYS, INC. (US) | 2009-03-05 | — | — | WO | disclosed |